Advertisement
Advertisement

ALXO

ALXO logo

ALX Oncology Holdings Inc. Common Stock

1.90
USD
Sponsored
+0.01
+0.53%
May 29, 15:59 UTC -4
Closed
exchange

After-Market

1.92

+0.02
+1.00%

ALX Oncology Holdings Inc. Common Stock Profile

About

ALX Oncology Holdings Inc.is a clinical-stage immuno-oncology company. It focuses on developing therapies for patients fighting cancer. The company's product candidate consist ALX148, which is in clinical stage. ALX Oncology Holdings Inc.is based in Burlingame, California.

Info & Links

CEO

Jason Lettmann

Headquarters

323 ALLERTON AVENUE
SOUTH SAN FRANCISCO, CA 94080, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.alxoncology.com

Auditor

KPMG LLP

Share holders

127

Employees

43

ALX Oncology Holdings Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

258.23M

Enterprise Value

234.45M

Enterprise Value/EBITDA(ttm)

-2.57

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

3.56

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-182.01%

Return on Invested Capital(ttm)

-186.87%

Return on Assets(ttm)

-113.63%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-91.16M

Net Income Available to Common(ttm)

-88.87M

Diluted EPS(ttm)

-1.90

Share Statistics

Beta (5Y Monthly)

0.49

52-Week Change

306.68%

S&P 500 52-Week Change

27.70%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

134.56M

Dividend Yield

0.00%

Float4

103.97M

% Held by Insiders

21.00%

% Held by Institutions

97.97%

Balance Sheet

Total Cash(mrq)

140.32M

Total Cash Per Share(mrq)

1.04

Total Debt(mrq)

8.51M

Total Debt/Equity(mrq)

37.52%

Current Ratio(mrq)

2.07%

Quick Ratio(mrq)

2.07%

Book Value Per Share(mrq)

0.48

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.57

Free Cash Flow(ytd)

-84.35M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement